For instance, some studies have suggested that ZNF185 acts as a tumor suppressor in prostate cancer [46], while others have proposed that the low expression of ZNF185 serves as a negative prognostic marker for colorectal cancer [32]. This evidence concerns the gene ZNF185 and prostate carcinoma.